{"title_page": "Functional gastrointestinal disorder", "text_new": "{{Infobox medical condition (new)\n| name          = \n| synonyms      = Disorders of gut\u2013brain interaction\n| image         = \n| caption       = \n| pronounce     = \n| field         = [[Gastroenterology]]\n| symptoms      = \n| complications = \n| onset         = \n| duration      = \n| types         = \n| causes        = \n| risks         = \n| diagnosis     = \n| differential  = \n| prevention    = \n| treatment     = \n| medication    = \n| prognosis     = \n| frequency     = \n| deaths        = \n| alt           = \n}}\n\n'''Functional gastrointestinal disorders''' ('''FGID'''), also known as '''disorders of gut\u2013brain interaction''', include a number of separate [[idiopathic]] disorders which affect different parts of the [[human gastrointestinal tract|gastrointestinal tract]] and involve [[visceral hypersensitivity]] and [[Gastrointestinal_physiology#Motility|motility]] disturbances.<ref name=\"pmid27144617\">{{cite journal |vauthors=Drossman DA |title=Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV |journal=Gastroenterology |volume=150 |issue=6 |pages=1262\u20131279|year=2016 |pmid=27144617 |doi=10.1053/j.gastro.2016.02.032 |url=https://semanticscholar.org/paper/ff3dda46f73a333f8d2a7a83177bc71ab4f41db0}}</ref>\n\n==Classification==\nTerms such as ''functional colonic disease'' (or ''functional bowel disorder'') refer in medicine to a group of [[bowel]] disorders which are characterised by chronic abdominal complaints without a structural or biochemical cause that could explain symptoms. Other ''functional'' disorders relate to other aspects of the process of [[digestion]].\n\nThe consensus review process of meetings and publications organised by the Rome Foundation, known as the [[Rome process]], has helped to define the functional gastrointestinal disorders.<ref name=\"urlRome Foundation // Scoring Rome III Questionnaire using SAS\">{{cite web |url=http://www.romecriteria.org/rome_iii_sas/ |title=Rome Foundation // Scoring Rome III Questionnaire using SAS |format= |accessdate=}}</ref> Successively, the Rome I, Rome II, Rome III and Rome IV proposed consensual classification system and terminology, as recommended by the Rome Coordinating Committee. These now include classifications appropriate for adults, children and neonates/toddlers.\n\nThe current Rome IV classification, published in 2016, is as follows:<ref name=\"pmid27144617\"/>\n\n'''A. Esophageal disorders'''\n*A1. Functional [[chest pain]] \n*A2. [[Functional heartburn]]\n*A3. [[Gastroesophageal reflux disease|Reflux]] hypersensitivity\n*A4. [[globus pharyngis|Globus]]\n*A5. Functional [[dysphagia]]\n\n'''B. Gastroduodenal disorders'''\n*B1. [[Functional dyspepsia]] \n**B1a. Postprandial distress syndrome (PDS)\n**B1b. Epigastric pain syndrome (EPS)  \n*B2. [[Belching]] disorders \n**B2a. Excessive supragastric belching  \n**B2b. Excessive gastric belching \n*B3. [[Nausea]] and [[vomiting]] disorders \n**B3a. Chronic nausea vomiting syndrome (CNVS)\n**B3b. [[Cyclic vomiting syndrome]] (CVS)\n**B3c. [[Cannabinoid hyperemesis syndrome]] (CHS)\n*B4. [[Rumination syndrome]]\n\n'''C. Bowel disorders'''\n*C1. [[Irritable bowel syndrome]] (IBS)\n**IBS with predominant constipation (IBS-C) \n**IBS with predominant diarrhea (IBS-D) \n**IBS with mixed bowel habits (IBS-M)\n**IBS unclassified (IBS-U) \n*C2. Functional [[constipation]]\n*C3. Functional [[diarrhea]]\n*C4. Functional abdominal [[bloating]]/distension  \n*C5. Unspecified functional bowel disorder \n*C6. [[Opioid-induced constipation]]\n\n'''D. Centrally mediated disorders of gastrointestinal pain'''\n*D1. Centrally mediated [[abdominal pain]] syndrome (CAPS) \n*D2. Narcotic bowel syndrome (NBS)/ Opioid-induced GI hyperalgesia\n\n'''E. Gallbladder and sphincter of Oddi disorders''' \n*E1. Biliary pain \n**E1a. Functional [[gallbladder]] disorder \n**E1b. Functional biliary [[sphincter of Oddi]] disorder \n*E2. Functional [[pancreas|pancreatic]] sphincter of Oddi disorder\n\n'''F. Anorectal disorders''' \n*F1. [[Fecal incontinence]] \n*F2. Functional anorectal pain\n**F2a. [[Levator ani]] syndrome\n**F2b. Unspecified functional anorectal pain \n**F2c. [[Proctalgia fugax]] \n*F3. Functional defecation disorders  \n**F3a. Inadequate defecatory propulsion \n**F3b. Dyssynergic defecation\n\n'''G. Childhood functional GI disorders: Neonate/Toddler'''\n*G1. Infant regurgitation\n*G2. Rumination syndrome  \n*G3. Cyclic vomiting syndrome (CVS)  \n*G4. [[Infant colic]]\n*G5. Functional diarrhea\n*G6. Infant [[dyschezia]]\n*G7. Functional constipation\n\n'''H. Childhood functional GI disorders: Child/Adolescent'''\n*H1. Functional nausea and vomiting disorders \n**H1a. Cyclic vomiting syndrome (CVS) \n**H1b. Functional nausea and functional vomiting \n***H1b1. Functional nausea \n***H1b2. Functional vomiting \n**H1c. Rumination syndrome \n**H1d. [[Aerophagia]]\n*H2. [[Chronic functional abdominal pain|Functional abdominal pain]] disorders \n**H2a. Functional dyspepsia \n***H2a1. Postprandial distress syndrome \n***H2a2. Epigastric pain syndrome \n**H2b. Irritable bowel syndrome (IBS) \n**H2c. [[Abdominal migraine]] \n**H2d. Functional abdominal pain \u2012 NOS\n*H3. Functional defecation disorders \n**H3a. Functional constipation \n**H3b. Nonretentive fecal incontinence\n\n==Epidemiology==\nFunctional gastrointestinal disorders are very common. Globally, irritable bowel syndrome and functional dyspepsia alone may affect 16\u201326% of the population.<ref name=\"pmid27144617\"/><ref name=\"pmid23160283\">{{cite journal |vauthors=Sperber AD, Drossman DA, Quigley EM |title=The global perspective on irritable bowel syndrome: a Rome Foundation-World Gastroenterology Organisation symposium |journal=Am. J. Gastroenterol. |volume=107 |issue=11 |pages=1602\u20139 |year=2012 |pmid=23160283 |doi=10.1038/ajg.2012.106 |url=}}</ref>\n\n==Research==\nThere is considerable research into the causes, diagnosis and treatments for FGIDs. Diet, microbiome, genetics, neuromuscular function and immunological response all interact.<ref name=\"pmid27144617\"/> A role for mast cell activation has been proposed as one of the factors.<ref name=\"FGID mast cell\">{{cite journal|vauthors=Wouters MM, Vicario M, Santos J|year=2015|title=The role of mast cells in functional GI disorders|journal=Gut|volume=65|issue=1|pages=155\u2013168|doi=10.1136/gutjnl-2015-309151|pmid=26194403|quote=It is well established that mast cell activation can generate epithelial and neuro-muscular dysfunction and promote visceral hypersensitivity and altered motility patterns in FGIDs, postoperative ileus, food allergy and inflammatory bowel disease.|doi-access=free}}</ref><ref>{{cite journal |last1=Bashashati |first1=M |last2=Moossavi |first2=S |last3=Cremon |first3=C |last4=Barbaro |first4=MR |last5=Moraveji |first5=S |last6=Talmon |first6=G |last7=Rezaei |first7=N |last8=Hughes |first8=PA |last9=Bian |first9=ZX |last10=Choi |first10=CH |last11=Lee |first11=OY |last12=Co\u00ebffier |first12=M |last13=Chang |first13=L |last14=Ohman |first14=L |last15=Schmulson |first15=MJ |last16=McCallum |first16=RW |last17=Simren |first17=M |last18=Sharkey |first18=KA |last19=Barbara |first19=G |title=Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis. |journal=Neurogastroenterology & Motility |date=January 2018 |volume=30 |issue=1 |pages=e13192 |doi=10.1111/nmo.13192 |pmid=28851005 |quote=Mast cells and CD3+ T cells are increased in colonic biopsies of patients with IBS vs non-inflamed controls}}</ref>\n\n==See also==\n* [[Allergy]]\n* [[Food intolerance]]\n* [[Histamine intolerance]]\n\n== References==\n{{reflist}}\n\n== External links ==\n{{Medical resources\n|  DiseasesDB      =  \n|  ICD10           =  \n|  ICD9            =  \n|  ICDO            =  \n|  OMIM            =  \n|  MedlinePlus     =  \n|  eMedicineSubj   =  \n|  eMedicineTopic  =  \n|  MeshID          = D003109 \n}}\n{{Drugs for functional gastrointestinal disorders}}\n{{Portal bar|Medicine}}\n\n[[Category:Gastrointestinal tract disorders]]\n", "text_old": "{{Infobox medical condition (new)\n| name            = \n| synonyms        = Disorders of gut-brain interaction\n| image           = \n| caption         = \n| pronounce       = \n| field           = [[Gastroenterology]]\n| symptoms        = \n| complications   = \n| onset           = \n| duration        = \n| types           = \n| causes          = \n| risks           = \n| diagnosis       = \n| differential    = \n| prevention      = \n| treatment       = \n| medication      = \n| prognosis       = \n| frequency       = \n| deaths          = \n}}\n\n'''Functional gastrointestinal disorders''' ('''FGID'''), also known as '''disorders of gut-brain interaction''' include a number of separate [[idiopathic]] disorders which affect different parts of the [[human gastrointestinal tract|gastrointestinal tract]] and involve [[visceral hypersensitivity]] and  [[Gastrointestinal_physiology#Motility|motility]] disturbances.<ref name=\"pmid27144617\">{{cite journal |vauthors=Drossman DA |title=Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV |journal=Gastroenterology |volume=150 |issue=6 |pages=1262\u20131279|year=2016 |pmid=27144617 |doi=10.1053/j.gastro.2016.02.032 |url=https://semanticscholar.org/paper/ff3dda46f73a333f8d2a7a83177bc71ab4f41db0}}</ref>\n\n==Classification==\nTerms such as ''functional colonic disease'' (or ''functional bowel disorder'') refer in medicine to a group of [[bowel]] disorders which are characterised by chronic abdominal complaints without a structural or biochemical cause that could explain symptoms.  Other ''functional'' disorders relate to other aspects of the process of [[digestion]].\n\nThe consensus review process of meetings and publications organised by the Rome Foundation, known as the [[Rome process]], has helped to define the functional gastrointestinal disorders.<ref name=\"urlRome Foundation // Scoring Rome III Questionnaire using SAS\">{{cite web |url=http://www.romecriteria.org/rome_iii_sas/ |title=Rome Foundation // Scoring Rome III Questionnaire using SAS |format= |accessdate=}}</ref> Successively, the Rome I, Rome II, Rome III and Rome IV proposed consensual classification system and terminology, as recommended by the Rome Coordinating Committee.  These now include classifications appropriate for adults, children and neonates/toddlers.\n\nThe current Rome IV classification, published in 2016, is as follows:<ref name=\"pmid27144617\"/>\n\n'''A. Esophageal disorders'''\n*A1. Functional [[chest pain]] \n*A2. [[Functional heartburn]]\n*A3. [[Gastroesophageal reflux disease|Reflux]] hypersensitivity\n*A4. [[globus pharyngis|Globus]]\n*A5. Functional [[dysphagia]]\n\n'''B. Gastroduodenal disorders'''\n*B1. [[Functional dyspepsia]] \n**B1a. Postprandial distress syndrome (PDS)\n**B1b. Epigastric pain syndrome (EPS)  \n*B2. [[Belching]] disorders \n**B2a. Excessive supragastric belching  \n**B2b. Excessive gastric belching \n*B3. [[Nausea]] and [[vomiting]] disorders \n**B3a. Chronic nausea vomiting syndrome (CNVS)\n**B3b. [[Cyclic vomiting syndrome]] (CVS)\n**B3c. [[Cannabinoid hyperemesis syndrome]] (CHS)\n*B4. [[Rumination syndrome]]\n\n'''C. Bowel disorders'''\n*C1. [[Irritable bowel syndrome]] (IBS)\n**IBS with predominant constipation (IBS-C) \n**IBS with predominant diarrhea (IBS-D) \n**IBS with mixed bowel habits (IBS-M)\n**IBS unclassified (IBS-U) \n*C2. Functional [[constipation]]\n*C3. Functional [[diarrhea]]\n*C4. Functional abdominal [[bloating]]/distension  \n*C5. Unspecified functional bowel disorder \n*C6. [[Opioid-induced constipation]]\n\n'''D. Centrally mediated disorders of gastrointestinal pain'''\n*D1. Centrally mediated [[abdominal pain]] syndrome (CAPS) \n*D2. Narcotic bowel syndrome (NBS)/ Opioid-induced GI hyperalgesia\n\n'''E. Gallbladder and sphincter of Oddi disorders''' \n*E1. Biliary pain \n**E1a. Functional [[gallbladder]] disorder \n**E1b. Functional biliary [[sphincter of Oddi]] disorder \n*E2. Functional [[pancreas|pancreatic]] sphincter of Oddi disorder\n\n'''F. Anorectal disorders''' \n*F1. [[Fecal incontinence]] \n*F2. Functional anorectal pain\n**F2a. [[Levator ani]] syndrome\n**F2b. Unspecified functional anorectal pain \n**F2c. [[Proctalgia fugax]] \n*F3. Functional defecation disorders  \n**F3a. Inadequate defecatory propulsion \n**F3b. Dyssynergic defecation\n\n'''G. Childhood functional GI disorders: Neonate/Toddler'''\n*G1. Infant regurgitation\n*G2. Rumination syndrome  \n*G3. Cyclic vomiting syndrome (CVS)  \n*G4. [[Infant colic]]\n*G5. Functional diarrhea\n*G6. Infant [[dyschezia]]\n*G7. Functional constipation\n\n'''H. Childhood functional GI disorders: Child/Adolescent'''\n*H1. Functional nausea and vomiting disorders \n**H1a. Cyclic vomiting syndrome (CVS) \n**H1b. Functional nausea and functional vomiting \n***H1b1. Functional nausea \n***H1b2. Functional vomiting \n**H1c. Rumination syndrome \n**H1d. [[Aerophagia]]\n*H2. [[Chronic functional abdominal pain|Functional abdominal pain]] disorders \n**H2a. Functional dyspepsia \n***H2a1. Postprandial distress syndrome \n***H2a2. Epigastric pain syndrome \n**H2b. Irritable bowel syndrome (IBS) \n**H2c. [[Abdominal migraine]] \n**H2d. Functional abdominal pain \u2012 NOS\n*H3. Functional defecation disorders \n**H3a. Functional constipation \n**H3b. Nonretentive fecal incontinence\n\n==Epidemiology==\nFunctional gastrointestinal disorders are very common. Globally, irritable bowel syndrome and functional dyspepsia alone may affect 16\u201326% of the population.<ref name=\"pmid27144617\"/><ref name=\"pmid23160283\">{{cite journal |vauthors=Sperber AD, Drossman DA, Quigley EM |title=The global perspective on irritable bowel syndrome: a Rome Foundation-World Gastroenterology Organisation symposium |journal=Am. J. Gastroenterol. |volume=107 |issue=11 |pages=1602\u20139 |year=2012 |pmid=23160283 |doi=10.1038/ajg.2012.106 |url=}}</ref>\n\n==Research==\nThere is considerable research into the causes, diagnosis and treatments for FGIDs.  Diet, microbiome, genetics, neuromuscular function and immunological response all interact.<ref name=\"pmid27144617\"/>  A role for mast cell activation has been proposed as one of the factors.<ref name=\"FGID mast cell\">{{cite journal|vauthors=Wouters MM, Vicario M, Santos J|year=2015|title=The role of mast cells in functional GI disorders|journal=Gut|volume=65|issue=1|pages=155\u2013168|doi=10.1136/gutjnl-2015-309151|pmid=26194403|quote=It is well established that mast cell activation can generate epithelial and neuro-muscular dysfunction and promote visceral hypersensitivity and altered motility patterns in FGIDs, postoperative ileus, food allergy and inflammatory bowel disease.|doi-access=free}}</ref><ref>{{cite journal |last1=Bashashati |first1=M |last2=Moossavi |first2=S |last3=Cremon |first3=C |last4=Barbaro |first4=MR |last5=Moraveji |first5=S |last6=Talmon |first6=G |last7=Rezaei |first7=N |last8=Hughes |first8=PA |last9=Bian |first9=ZX |last10=Choi |first10=CH |last11=Lee |first11=OY |last12=Co\u00ebffier |first12=M |last13=Chang |first13=L |last14=Ohman |first14=L |last15=Schmulson |first15=MJ |last16=McCallum |first16=RW |last17=Simren |first17=M |last18=Sharkey |first18=KA |last19=Barbara |first19=G |title=Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis. |journal=Neurogastroenterology & Motility |date=January 2018 |volume=30 |issue=1 |pages=e13192 |doi=10.1111/nmo.13192 |pmid=28851005 |quote=Mast cells and CD3+ T cells are increased in colonic biopsies of patients with IBS vs non-inflamed controls}}</ref>\n\n==See also==\n* [[Allergy]]\n* [[Food intolerance]]\n* [[Histamine intolerance]]\n\n== References==\n{{reflist}}\n\n== External links ==\n{{Medical resources\n|  DiseasesDB      =  \n|  ICD10           =  \n|  ICD9            =  \n|  ICDO            =  \n|  OMIM            =  \n|  MedlinePlus     =  \n|  eMedicineSubj   =  \n|  eMedicineTopic  =  \n|  MeshID          = D003109 \n}}\n{{Drugs for functional gastrointestinal disorders}}\n{{Portal bar|Medicine}}\n\n[[Category:Gastrointestinal tract disorders]]\n", "name_user": "Lymoz", "label": "safe", "comment": "Did some minor cleaning.", "url_page": "//en.wikipedia.org/wiki/Functional_gastrointestinal_disorder"}
